You are here

  • Home
  • Archive
  • Volume 10, Issue 5
  • Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developing a prognostic multivariate model

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developing a prognostic multivariate model

 

Online download statistics by month:

Online download statistics by month: May 2022 to September 2025

AbstractFullPdf
May 2022665683267
Jun 2022713741138
Jul 2022681706182
Aug 2022641654107
Sep 202222923882
Oct 202220520951
Nov 202217217670
Dec 202213213641
Jan 202313714035
Feb 202311811935
Mar 20239810053
Apr 2023868730
May 2023969731
Jun 2023787925
Jul 2023838430
Aug 2023767743
Sep 2023616135
Oct 2023757632
Nov 2023818122
Dec 2023565725
Jan 2024727254
Feb 2024747441
Mar 20248585119
Apr 2024909048
May 2024889238
Jun 202410110158
Jul 2024676922
Aug 2024615923
Sep 2024727339
Oct 2024616139
Nov 2024666737
Dec 2024747658
Jan 2025767845
Feb 202516216247
Mar 2025747629
Apr 202512512560
May 2025707439
Jun 2025646531
Jul 2025110
Sep 2025110
Total596761022161